Abstract
The preparation, application and clinical usage of 99mTc-mercaptoacetyltriglycine, MAG3, a tubular secreted compound, is described in the first 225 patients in a phase III study. Image quality, relative renal function, and renal transit times were compared with a 4 fold greater administered activity of 99mTc-DTPA in 11 patients. Correlation coefficients of 0.94 for relative function, 0.83 for parenchymal transit time index and 0.82 for whole kidney transit time index were found. Frusemide responses were similar. 99mTc-MAG3 is an efficacious radiopharmaceutical for routine renal radionuclide studies, giving excellent image quality in patients with hypertension, poor renal function, obstructive nephropathy or a renal transplant.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Barbour GL, Crumm CK, Boyd CM (1976) Comparison of inulin, iothalamate, and 99m-technetium DTPA for measurement of glomerular filtration rate. J Nucl Med 17:317–320
Bomanji L, Boddy SAM, Britton KE, Nimmon CC, Whitfield HN (1987) Radionuclide evaluation of pre- and post-extracorporeal shock wave lithotripsy for renal calculi. J Nucl Med 28:1234–1289
Britton KE (1980) Dynamic radionuclide imaging. Br Med Bull 36:215–222
Britton KE, Brown NJG (1971) Clinical Renography. Lloyd: London
Britton KE, Nimmon CC, Whitfield HN (1980) The evaluation of obstructive nephropathy by means of parenchymal retention functions. In: Hollenberg NK, Lange S (eds) Radionuclides in Nephrology. Thieme, Stuttgart, pp 164–172
Britton KE, Maisey MN (1983) In: Maisey MN, Britton KE, Gilday DL (eds) Renal radionuclide studies. Clinical Nuclear Medicine. Chapman and Hall, London, pp 93–120
Britton KE, Nawaz MK, Whitfield HN, Nimmon CC, Carroll MJ, Granowska M, Mlodkowska E (1987) Obstructive nephropathy; comparison between parenchymal transit time index and frusemide diuresis. Br J Urol 59:127–132
Bubeck B, Brandau W, Eisenhut M, Weidenhammer K, Georgi P (1987) The tubular extraction rate (TER) of 99m-Tc-MAG3: A new quantitative parameter of renal function. Nuc Compact 18:260–267
Davison A, Jones A, Orvig C, Sohn M (1981) A new class of oxotechnetium (+5) chelate complexes containing a TcON2S2 core. Inorg Chem 20:1629–1632
Elliott AT, Britton KE (1978) A review of the physiological parameters in the dosimetry of 123-I and 131-I labelled Hippuran. Int J Appl Rad Isot 29:571–573
Fritzberg AR, Klingensmith WC, Whitney WD, Kuni CC (1981) Chemical and biological studies of Tc-99m N,N′-bis(mercaptoacetamido)-ethylenediamine: A potential replacement for (I-131)-O-iodohippurate. J Nucl Med 22:258–263
Fritzberg AR, Kuni CC, Klingensmith WC (1982) Synthesis and biological evaluation of Tc-99m N-N′-bis(mercaptoacetyl)-2,3-diaminopropanoate: A potential replacement for I-131 hippuran. J Nucl Med 23:592–598
Fritzberg AR, Kasina E, Eshima D, Johnson DL (1986) Synthesis and biological evaluation of technetium 99-m MAG-3 as a hippuran replacement. J Nucl Med 27:111–116
Gruenewald SM, Collins LT (1983) Renovascular hypertension: quantitative renography as a screening test. Radiology 149:287–291
Hauser W, Atkins HL, Nelson KG, Richards P (1970) Technetium-99m DTPA: A new radiopharmaceutical for brain and kidney scanning. Radiology 94:679–684
Hilson AJW, Maisey MN, Brown CB, Ogg CS, Bewick MS (1979) Dynamic renal transplant imaging with Tc-99m DTPA(Sn) supplemented by a transplant perfusion index in the management of renal transplants. J Nucl Med 19:994–1000
Jafri RA, Nimmon CC, Britton KE, Al-Nahhas A, Bomanji J, Solanki K, Fettich J, Hawkins LA (1987) MAG3, 99m-Tc-mercaptoacetyl-triglycine and OIH, ortho-iodohippurate, a comparison. Abstract to the 15th annual BNMS Meeting, London. Nucl Med Comm 8:289
Jafri RA, Britton KE, Nimmon CC (1988) 99m-Tc MAG3: A comparison with I-123 and I-131 orthoiodohippurate in patients with renal disorder. J Nucl Med 29:147–158
Klingensmith WC III, Gerhold JP, Fritzberg AR (1982) Clinical comparison of Tc-99m N,N′-bis(mercaptoacetamido)-ethylenediamine and (131-I) ortho-iodohippurate for evaluation of renal tubular function. Concise Communication. J Nucl Med 23:377–386
Klingensmith WC, Fritzberg AR, Spitzer VM (1983) Clinical evaluation of Tc-99m N,N′bis(mercaptoacetyl)-2,3-diaminopropanoate as a replacement for I-131 hippuran. J Nucl Med 24:80 (abstr.)
Klingensmith WC III, Fritzberg AR, Spitzer VM, Johnson DL, Kuni CC, Williamson MR, Waser G, Weil R (1984) Clinical evaluation of Tc-99m N,N′-bis(mercaptoacetyl)-2,3-diaminopropanoate as a replacement for I-131 hippurate. Concise Communication. J Nucl Med 25:42–48
Nimmon CC, Lee TY, Britton KE, Granowska M, Gruenewald SM (1981) Practical applications of deconvolution techniques to dynamic studies. In: Medical Radionuclide Imaging. International Atomic Energy Agency, Vienna. Volume I pp 367–387
Page IH, McCubbin JW (1968) Renal Hypertension. Year Book medical publishers, Chicago
Taylor AT (1980) Quantitative renal function scanning: A historical and current status report on renal radiopharmaceuticals. In: Freeman LM, Weissman HS (eds) Nuclear Medicine Annual, Raven Press, New York, pp 303–340
Taylor A, Eshima D, Fritzberg AR (1986) Comparison of I-131 OIH and Tc-99m MAG3, renal imaging in volunteers. J Nucl Med 27:795–803
Taylor A, Eshima D, Alazraki N (1987) 99m-Tc-MAG3, a new renal imaging agent: Preliminary results in patients. Eur J Nucl Med 12:510–514
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Al-Nahhas, A.A., Jafri, R.A., Britton, K.E. et al. Clinical experience with 99mTc-MAG3, mercaptoacetyltriglycine, and a comparison with 99mTc-DTPA. Eur J Nucl Med 14, 453–462 (1988). https://doi.org/10.1007/BF00252388
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00252388